Global
Dementia & Alzheimer Disease Market By Drug Class (Cholinergic,
Memantine, Combined Drug), Distribution Channel (Hospital Pharmacy, Retail
Pharmacy, Online Sales), Geography (North America, South America, Europe,
Asia-Pacific, Middle East and Africa) - Forecast to 2025
The global dementia & alzheimer disease market is
expected to grow significantly during the forecast period of 2018 to 2025. The
upcoming market report contains data for historic years 2016, the base year of
calculation is 2017 and the forecast period is 2018 to 2025.
Get Sample Copy of this Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-dementia-alzheimer-disease-market
Major Market
Competitors/Players: Global Dementia & Alzheimer Disease Market
·
Ono Pharmaceutical
·
Daiichi Sankyo Company Limited
·
H Lundbeck A/S
·
Johnson & Johnson
·
Eisai Co Ltd.
·
Pfizer, Inc.
·
Janssen Pharmaceutical
·
Novartis International AG
·
Eisai Co. Ltd.
·
Lundbeck A/S
·
Teva Pharmaceuticals Industries Ltd.
·
Eli Lilly and Company
·
TauRx Pharmaceuticals Ltd
·
VTV Therapeutics
·
Hoffman-La Roche Ltd.
·
AstraZeneca plc
·
AC Immune
·
Among others
Competitive Analysis:
The global dementia & alzheimer disease market is highly
fragmented and the major players have used various strategies such as new
product launches, expansions, agreements, joint ventures, partnerships,
acquisitions, and others to increase their footprints in this market. The
report includes market shares of dementia & alzheimer disease market for
global, Europe, North America, Asia Pacific and South America.
Market Definition:
Global Dementia & Alzheimer Disease Market
The most common cause of dementia is Alzheimer’s disease.
Dementia is a group of co-occurring signs and symptoms that includes
progressive worsening of intellectual role.
Dementia defines number of symptoms which contains memory loss and problems
with thinking, problem-solving or language. These types of indications
generally happen when the brain is injured by particular diseases, counting
Alzheimer’s illness Numerous cognitive abilities are reduced with dementia,
including language, attention, memory, reasoning, visuospatial function,
decision making, orientation and others. People with dementia and cognitive
impairments often suffer with change in personality, emotional regulation, and
social behaviors. Significantly, the intellectual and behavioral changes occur
with dementia that can interfere with work, social activities, relationships
and damage a person’s ability to perform routine daily activities (e.g.,
driving, shopping, housekeeping, cooking, managing finances, and personal
care). Common symptoms of dementia include the gradual loss of memory, decline
in communication skills and difficulty with thinking and reasoning.
According to the World Health Organization, cost of
treatment of dementia is more than USD 604 billion per year. This includes the
cost of providing health and social care as well the reduction or loss of
income of people with dementia and their caregivers.
Market Drivers and
Restraints:
·
Growing prevalence of Alzheimer’s disease
·
Increasing awareness about the treatment of
Alzheimer’s disease
·
High treatment cost
·
Side effects of the disease treatment
Market Segmentation:
Based on drug class:
·
Cholinergic
·
Memantine
·
Combined Drug
On the basis of distribution channel:
·
Hospital Pharmacy
·
Retail Pharmacy
·
Online Sales
Based on geography:
·
North America
·
South America
·
Europe
·
Asia-Pacific
·
Middle East & Africa
Some of the major countries covered in this report are:
·
U.S.
·
Canada
·
Germany
·
France
·
U.K.
·
Netherlands
·
Switzerland
·
Turkey
·
Russia
·
China
·
India
·
South Korea
·
Japan
·
Australia
·
Singapore
·
Saudi Arabia
·
South Africa
·
Brazil
·
Among others
Order a Copy of Global Dementia & Alzheimer
Disease Market Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-dementia-alzheimer-disease-market
Key Developments in
the Market:
In January 2018, Dthera Sciences (U.S.), launched ReminX,
which is an artificial-intelligence-powered consumer health product designed to
digitally deliver reminiscence therapy to individuals suffering from
Alzheimer’s and other dementias.
In July 2018, ADI (U.S.) and Global Coalition on Aging
(GCOA) (U.S.) launched the Dementia Innovation Readiness Index during ADI’s
33rd International Conference in Chicago. This Index can be used to analyze the
readiness of countries to develop and organize dementia solutions into their
healthcare, policy and social frameworks.
Reasons to Purchase
this Report:
·
Current and future of global dementia
& alzheimer disease market outlook in the developed and emerging
markets
·
The segment that is expected to dominate the
market as well as the segment which holds highest CAGR in the forecast period.
·
Regions/countries that are expected to witness
the fastest growth rates during the forecast period
·
The latest developments, market shares, and
strategies that are employed by the major market players
Customization of the
Report:
·
The report includes the complete segmentation
displayed above across all above mentioned countries
·
All products covered in the market, product
volume and average selling prices will be included as customizable options
which may incur no or minimal additional cost (depends on customization)
View Full Report @ https://databridgemarketresearch.com/reports/global-dementia-alzheimer-disease-market/
About Data Bridge
Market Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric Market
research and consulting firm with unparalleled level of resxlience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818